A deluge of new data does not suggest harm with ACE inhibitors and angiotensin blockers in COVID-19 rates or outcomes but suggests possible differential effects of the two drug classes.
from WebMD Health https://www.webmd.com/lung/news/20200505/new-angiotensin-studies-in-covid-19-give-more-reassurance?src=RSS_PUBLIC
0 Comments:
Post a Comment